Dino A. Rossi, Director at Krystal Biotech, Inc. (KRYS), sold 28,691 shares at $325.60 ($8.2M) on 2026-08-14, disclosed to the SEC on 2026-08-14.
Open-market sale of $8.2M KRYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,691 | $0 | 0.0% |
| 2 | $325.60 | 341 | $111K | 1.3% |
| 3 | $326.60 | 2,287 | $747K | 9.1% |
| 4 | $327.39 | 5,226 | $1.7M | 20.8% |
| 5 | $328.52 | 1,687 | $554K | 6.7% |
| 6 | $329.60 | 7,428 |
| $2.4M |
| 29.8% |
| 7 | $330.36 | 4,896 | $1.6M | 19.7% |
| 8 | $331.43 | 3,095 | $1.0M | 12.5% |
| 9 | $333.23 | 40 | $13K | 0.2% |
| Total | $286.78 avg | 28,691 | $8.2M | 100% |
| Filing → |
| BCPC | SELL | 2017-01-06 | $124K | — | Filing → |
| BCPC | SELL | 2016-12-08 | $2.2M | — | Filing → |
| BCPC | SELL | 2016-11-16 | $1.3M | — | Filing → |